Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial Sherar,

PURPOSE The objective of this study was to determine whether the thermal dose delivered during hyperthermia treatments and other thermal factors correlate with outcome after combined radiation and hyperthermia of breast carcinoma recurrences. Data were from the combined hyperthermia and radiation treatment arms of four Phase III trials, which when pooled together, demonstrated a positive effect of hyperthermia. METHODS AND MATERIALS Four Phase III trials addressing the question of whether hyperthermia could improve the local response of superficial recurrent breast cancer to radiation therapy were combined into a single analysis. Thermal dosimetry data were collected from 120 of the 148 breast cancer recurrence patients who received hyperthermia. The data were analyzed for correlations between thermal parameters as well as important clinical parameters and outcome (complete response rate, local disease free survival, time to local failure, and overall survival). RESULTS Five thermal parameters were tested, all associated with the low regions of the measured temperature distributions. Max(TDmin) and Sum(TDmin) were associated with complete response where TDmin is the minimum thermal dose measured by any of the tumor temperature sensors during a treatment: Max(TDmin) is the maximum of TDmin over a series of treatments. Using a categorical relationship with a cutoff of 10 min for Sum(TDmin), the complete response rate was 77% for Sum(TDmin) > 10 min and 43% for Sum(TDmin) < or = 10 min (p = 0.022, adjusted for study center and significant clinical factors). The overall complete response rate for hyperthermia and radiation was 61% compared to 41% for radiation alone. Either Max(TDmin) or Sum(TDmin) were also associated with local disease free survival, time to local failure and overall survival. CONCLUSIONS An earlier report of this trial demonstrated a significant benefit when hyperthermia was added to radiation in the treatment of breast cancer recurrences. The analysis of thermal factors demonstrates that parameters representative of the low end of the measured temperature distributions are associated with initial complete response rate, local disease-free survival, time to local failure and overall survival.

[1]  S. B. Field,et al.  An assessment of local hyperthermia in clinical practice. , 1986, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[2]  W. F. White,et al.  Once weekly irradiation for carcinoma of the bladder. , 1996, International journal of radiation oncology, biology, physics.

[3]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .

[4]  J. Sylvester,et al.  Clinical application of thermal isoeffect dose. , 1987, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[5]  G. Hahn,et al.  Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses: results of a randomized trial. , 1990, International journal of radiation oncology, biology, physics.

[6]  R S Cox,et al.  Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. , 1995, International journal of radiation oncology, biology, physics.

[7]  C. Perez,et al.  Hyperthermia in combination with definitive radiation therapy: results of a Phase I/II RTOG Study. , 1988, International journal of radiation oncology, biology, physics.

[8]  G. Lovisolo,et al.  Tumour response to heat and radiation: prognostic variables in the treatment of neck node metastases from head and neck cancer. , 1985, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[9]  M. Amichetti,et al.  Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: a prospective randomized clinical trial. , 1987, International journal of radiation oncology, biology, physics.

[10]  David Machin,et al.  Survival Analysis: A Practical Approach , 1995 .

[11]  M. Dewhirst,et al.  Characterization of tumour temperature distributions in hyperthermia based on assumed mathematical forms. , 1989, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[12]  P. Rubin,et al.  Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: a Report by the Radiation Therapy Oncology Group. , 1989, International journal of radiation oncology, biology, physics.

[13]  M. Dewhirst,et al.  The utility of thermal dose as a predictor of tumor and normal tissue responses to combined radiation and hyperthermia. , 1984, Cancer research.

[14]  L. Blank,et al.  Radiotherapy and hyperthermia. , 1995, European journal of cancer.

[15]  M. Amichetti,et al.  Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. , 1994, International journal of radiation oncology, biology, physics.

[16]  D Machin,et al.  Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. , 1996, International journal of radiation oncology, biology, physics.

[17]  D. Kapp,et al.  Efficacy of adjuvant hyperthermia in the treatment of superficial recurrent breast cancer: confirmation and future directions. , 1996, International journal of radiation oncology, biology, physics.

[18]  S L George,et al.  Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. , 1993, International journal of radiation oncology, biology, physics.

[19]  D. Kapp,et al.  Hyperthermia and radiation therapy of local-regional recurrent breast cancer: prognostic factors for response and local control of diffuse or nodular tumors. , 1991, International journal of radiation oncology, biology, physics.

[20]  A. Markoe,et al.  Superficial chest wall recurrences of breast cancer: prognostic treatment factors for combined radiation therapy and hyperthermia. , 1989, Radiology.

[21]  J. van der Zee,et al.  Retrospective analysis of the response of tumours in patients treated with a combination of radiotherapy and hyperthermia. , 1986, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[22]  O Mella,et al.  Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. , 2009, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[23]  Eduardo G. Moros,et al.  Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: A prospectively controlled randomized study by the radiation therapy oncology group , 1993 .

[24]  W. Dewey,et al.  Thermal dose determination in cancer therapy. , 1984, International journal of radiation oncology, biology, physics.

[25]  S. Han,et al.  Platelet-derived growth factor (PDGF)-signaling mediates radiation-induced apoptosis in human prostate cancer cells with loss of p53 function. , 1997, International journal of radiation oncology, biology, physics.

[26]  Foi J. McCraw,et al.  Evaluation of equipment for hyperthermic treatment of cancer. , 1988, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[27]  J R Oleson,et al.  Analysis of prognostic variables in hyperthermia treatment of 161 patients. , 1984, International journal of radiation oncology, biology, physics.

[28]  D. Collett,et al.  Modelling Binary Data. , 1994 .

[29]  M. Benassi,et al.  Radiotherapy and hyperthermia. Analysis of clinical results and identification of prognostic variables , 1987, Cancer.

[30]  L Tupchong,et al.  Randomized Phase III Study Comparing Irradiation and Hyperthermia with Irradiation Alone in Superficial Measurable Tumors: Final Report by the Radiation Therapy Oncology Group , 1991, American journal of clinical oncology.

[31]  A. Harris,et al.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.

[32]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.